Tri Locum Partners LP Takes Position in The Cigna Group (NYSE:CI)

Tri Locum Partners LP purchased a new stake in shares of The Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 40,810 shares of the health services provider's stock, valued at approximately $11,269,000. The Cigna Group comprises approximately 2.3% of Tri Locum Partners LP's holdings, making the stock its 19th biggest position.

Other large investors have also made changes to their positions in the company. TCTC Holdings LLC acquired a new position in shares of The Cigna Group during the 4th quarter valued at about $25,000. Collier Financial bought a new position in shares of The Cigna Group in the fourth quarter valued at approximately $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group in the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA acquired a new stake in shares of The Cigna Group in the fourth quarter worth $37,000. Finally, Transce3nd LLC bought a new stake in shares of The Cigna Group during the 4th quarter worth $38,000. Institutional investors own 86.99% of the company's stock.

The Cigna Group Price Performance

NYSE CI traded down $3.17 on Friday, hitting $332.02. 1,239,123 shares of the company were exchanged, compared to its average volume of 1,702,794. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a market cap of $90.87 billion, a P/E ratio of 27.14, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The firm has a 50 day moving average of $322.82 and a two-hundred day moving average of $310.34.

The Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The business's quarterly revenue was up 14.4% compared to the same quarter last year. During the same period last year, the company earned $6.47 EPS. On average, equities analysts predict that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is presently 49.35%.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Morgan Stanley cut their target price on shares of The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Wells Fargo & Company decreased their target price on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research note on Tuesday, February 4th. Mizuho raised their target price on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Cantor Fitzgerald increased their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a report on Thursday, March 20th. Finally, Guggenheim started coverage on The Cigna Group in a report on Wednesday, April 9th. They issued a "buy" rating and a $384.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group currently has a consensus rating of "Buy" and an average price target of $373.56.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO David Cordani sold 26,527 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,751 shares of company stock worth $13,603,991. Insiders own 0.70% of the company's stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.